Remove about
article thumbnail

Public Health Product Hops

Bill of Health

Yet Dmitry Karshtedt held otherwise at the ASLME Health Law Professor’s Conference in Atlanta, GA in 2017. The first draft was completed about a week before Dmitry’s death, and it was workshopped for the first time with Professor I. Could Congress or the FDA have incentivized the manufacturer to initiate the switch much sooner?

article thumbnail

EU and US Regulatory Challenges Facing AI Health Care Innovator Firms

Bill of Health

Beyond the health care sector-specific Medical Devices Regulation (EU) 2017/745 (MDR) and the In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR), this mix of AI & Data related regulatory requirements stems from a series of generalized, cross-sectoral EU laws of the last 5 years.

FDA 282
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Privatization of Cancer

Bill of Health

In fact, the majority of Americans do not hold strong trust in our health agencies like FDA and CDC. In 2017, 72% of U.S. Many readers might be thinking, “What about screening?” There is an intuitive sense that products are not well regulated, leaving individuals to moderate their own cancer risk.

FDA 301
article thumbnail

Five Reasons why the FDA got it Right with Digital Health

The Digital Health Corner

The FDA recently announced its Digital Health Innovation Action Plan. Digital health differs significantly from drugs and traditional medical devices around which the FDA has developed its structure and policies over decades. The FDA will have new digital health experts. This plan was both important and necessary.

FDA 87
article thumbnail

Unpacking Averages: Searching for Bias in Word Embeddings Trained on FDA Regulatory Documents

Health Law Advisor

Often when we talk about bias in word embeddings, we are talking about such things as bias against race or sex. But I’m going to talk about bias a little bit more generally to explore attitudes we have that are manifest in the words we use about any number of topics. Instead, I’m going to look for bias in other topics.

FDA 40
article thumbnail

FDA Guidance Shows a Regulatory Path Forward for Interoperable Devices

Exeed Regulatory Compliance

A new FDA guidance offers helpful recommendations for design and premarket submission. According to a 2018 Deloitte Consulting report, the market for interconnected medical devices is expected to grow from $15 billion in 2017 to $52 billion by 2025. Medical device industry is changing fast!

FDA 52
article thumbnail

False and Deceptive Health Claims: Buyers Beware

Bill of Health

The FDA’s primary responsibility is over claims that appear on product labels (including packaging, product inserts, and promotional material at the point of sale), and the FTC regulates claims made in advertising in general. FDA regulations prescribe different standards for different products and claims. million to consumers.

FDA 184